Pediatric rheumatologist, Notre Dame alum, sports fan, chocoholic, SCUBA diver, traveler... not always in that order. Opinions are my own.

Joined December 2013
🚨 New ACR Guidelines just released for Axisl Spondyloarthritis
New! Axial SpA Guideline Summary Just Released A new ACR clinical practice guideline summary is now available and provides evidence-based and expert guidance for the diagnosis and management of axial spondyloarthritis (axSpA) and associated extra-musculoskeletal manifestations (EMMs) in adults and children and adolescents. MORE → acr.tw/4eEcNUd
5
479
Thank you to @carrainc for supporting the launch of PREIM! If you are in #pedsrheum, are a fellow or EI, and have an interest in research, this FREE meeting is for you! Hope to see you there! #PREIM26
🎉We’re excited to launch the first Pediatric Rheumatology Early Investigator Meeting (PREIM) at PRSYM! It is open to fellows and early-career investigators in #pedsrheum, and it's free to attend!💙 Big thanks to @DrTinyTree! 🙌 Register by Feb. 15 ➡️ carra.tfaforms.net/75
1
1
2
166
#ACR25—what an incredible week! 🙌 We welcomed over 13,000 attendees from more than 100 countries. Thank you to the global rheumatology community for an unforgettable event. 🌎 See you at #ACR26 in Orlando, Florida, November 6-11, 2026! 🌴
1
6
1
18
1,751
Scenes from #ACR25. Pediatric Rheumatology Kahoot!—2nd year in a row & some friendly competition. Hosted by Pui Lee, MD, PhD, & Susan Shenoi, MD, MS. #pedsrheum
3
9
1,016
Great session this morning on hard-to-treat cases of juvenile localized scleroderma. I’m always glad to see ⁦my favorite pediatric rheumatologist Dr. Suzanne Li sharing her expertise to help others! #ACR25 #ACRAmbassador
1
5
302
Puppies at #ACR25!! They are in the exhibit hall until 4 PM. #ACRambassador
1
1
4
1,104
Dr. Bas Vastert, Care Transformation in Childhood Arthritis via Precision Medicine: Window of opportunity ⭐️in non-systemic #JIA: ⬆️ inactive disease with earlier biologic start (<6mo) ⭐️in sJIA: integrating biomarkers in clinical care, early targeted tx #ACR25 #ACRambassador
1
1
112
Dr. Bas Vastert, Care Transformation in Childhood Arthritis via Precision Medicine: sJIA treatment ⭐️cytokine monitoring, especially IL-18 ⭐️T2T with biologic first approach in Netherlands- most patients don’t receive any GCs #ACR25 #ACRambassador
1
74
Dr. Rae Yeung, Understanding and Harnessing the Biology of Arthritis 1. JIA classification has been a journey. Not every patient finds a home, & peds doesn’t consistently translate to adult classification. Is there a way to do this from a biologic basis? #ACR25 #ACRambassador
1
1
2
143
Dr. Rae Yeung, Understanding and Harnessing the Biology of Arthritis 3. UCAN Biologic Classification: lots of patients and large amount of data yielded 5 clusters with clinical and biologic characteristics and distinct patterns of joint involvement #ACR25 #ACRambassador
1
1
1
60
Dr. Rae Yeung, Understanding and Harnessing the Biology of Arthritis 4. Naming is important because guides therapy #ACR25 #ACRambassador #kidsgetarthritistoo
2
2
86
Looking forward to starting my day off in the Networking Lounges for the AMIGO event at 8:20 AM. Hope to see many fellow #pedsrheum there! #ACR25 #ACRambassador
1
87
Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Guidelines -EULAR/PReS Still’s Guidelines -French protocol for treatment of #JIA -ACR Guidance for Mental Health #ACRambassador
1
1
95
Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Understanding Disease -ANA positive ITP patients have higher rates of SLE and Sjogren -Specific inborn errors of immunity are at increased risk of ANCA and AAV features #ACRambassador
1
2
117
Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Social Media 🚨 opportunity for increased healthcare provider engagement #ACRambassador
2
71
Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Deprescribing -a large number of patients JIA flare off therapy -lower uveitis recurrence with slower ADA tapering schedule #ACRambassador
1
1
120
Dr. Karen Onel presents #ACR25 #pedsrheum Clinical Year in Review: Medications -New FDA approvals: emapalumab, guselkumab -CAR-T cells in #JDM: a child with aggressive JDM achieved remission -Stem cell transplant: high morbidity, those who survive do well #ACRambassador
1
93
#ACR25 #pedsrheum Basic & Translational Year in Review: JIA pubmed.ncbi.nlm.nih.gov/4060… -Synovial tissue 🚫 peripheral blood and synovial fluid pubmed.ncbi.nlm.nih.gov/4009… -B cells in JIA sunovial fluid and mostly switched memory B cells, especially girls -Autoantibodies are abundant
2
76
#ACR25 #pedsrheum Basic & Translational Year in Review: JDM insight.jci.org/articles/vie… and pubmed.ncbi.nlm.nih.gov/4078… -high IFN score, low mitochondrial score in skin pubmed.ncbi.nlm.nih.gov/4078… -identified pathways associated with MSA subtypes that reflect JDM phenotypes
1
64
#ACR25 #pedsrheum Basic & Translational Year in Review by Dr. Peter Nigrovic: SLE
1
53